Live
Ajanta Pharma Ltd’s shares were up 5 per cent at Rs 2,160 on the Bombay Stock Exchange in Friday’s intra-day trade after the company said its board would meet on December 28 to consider a share buyback plan.
“The meeting of the board of directors of the Company is scheduled on Tuesday, December 28, 2021, to consider a proposal for buy-back of equity shares including matters related /incidental to it,” Ajanta Pharma said.
- India Approves 25 LMT Wheat, 5 LMT Sugar Export Quota
- US Core Inflation Seen at 5-Year Low Ahead of Friday Report
- Shilpa Medicare Signs NCE Pact with NXI; Shares End 1% Up
- Dilip Buildcon Wins Rs 124 Cr PNGRB ATF Project; Stock Down 3.5%
- Natco Pharma Shares Slump 2% as the USFDA Issued 7 Observations
Buyback is a corporate action in which a company buys back its shares from the existing shareholders, usually higher than the market price. When it buys back shares, the number of outstanding shares in the market reduces.
Stock Covered in the news
